4

Document Details

Form
Filing Date
Feb 23, 2022
Document Date
Feb 18, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Spero Therapeutics, Inc.
Issuer
Spero Therapeutics, Inc.